|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Non-operating income (expense), net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of warrant liability and contingent earn-out shares | |||||
| Other expense, net: | |||||
| Total non-operating income, net | |||||
| Income (loss) before provision for income taxes | |||||
| Benefit from income taxes | |||||
| Net loss | |||||
| Redeemable convertible preferred stock dividends - undeclared and cumulative | |||||
| Other comprehensive gain: | |||||
| Unrealized gain on investments, net | |||||
| Comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic | |||||
| Net loss per share attributable to common stockholders, diluted | |||||
| Weighted-average common shares used to compute net loss per share, basic | |||||
| Weighted-average common shares used to compute net loss per share, diluted | |||||
Loading...